4325081
Inhibiting viral infections with glycopolymers: Accessing non-linear antiviral polymers through reversible addition–fragmentation chain-transfer polymerizations
Date
August 19, 2025
Related Products
Glycopolymers for antiviral and antibacterial applications
Infections caused by bacterial and viral pathogens are one of the most pressing challenges in healthcare. Resistance to current therapies continues to develop, necessitating new approaches to treating infectious disease…
Inhibiting norovirus infections via modular hyperbranched polymers with terminal glycan moieties | Poster Board #899
Norovirus is a large family of highly infectious gastrointestinal viruses that annually infect nearly 700 million people and cause hundreds of thousands of deaths per year. Designing vaccines and antivirals has met numerous obstacles and there are currently no FDA-approved treatments…
Glycopolymers for antiviral and antibacterial applications
Infections caused by bacterial and viral pathogens are one of the most pressing challenges in healthcare. Resistance to current therapies continues to develop, necessitating new approaches to treating infectious disease…
Developing sialic acid-conjugated poly(styrene sulfonate) for rotavirus inhibition: Synthesis and structure-activity analysis
Rotavirus is a leading cause of severe gastroenteritis in children worldwide. As no specific anti-rotavirus drugs are currently available, there is a growing interest in materials-based strategies that can inhibit viral infection through molecular recognition…